Date of teleconference participation:
|
|
1. As a result of completing this learning activity, are you now better able to:
|
 |
a. |
Describe the role of aldosterone in the pathophysiology of heart failure? |
|
|
 |
b. |
State the results of recent trials involving aldosterone blockers? |
|
|
 |
c. |
Use aldosterone blockade safely and effectively in patients with post-MI heart failure, particularly with regard to risk factors for hyperkalemia? |
|
|
| 2. Were the objectives of this learning activity related to its overall
goal? |
|
| 3. Was the content of this learning activity clearly written? |
|
| 4. Was the content scientifically rigorous? |
|
| 5. Was the content of this activity free of
commercial bias? |
|
| 6. Was the information/content relevant to your clinical practice? |
|
| 7. Did the format of this activity promote learning? |
|
|
| |
| If you answered no or somewhat to
any items above, please explain: |
|
| |
| I certify that I have completed this activity. |
| |
| Please type your full name and degree (this will act as your “electronic
signature”): |
|
| |
| Please enter today’s date: |
|
| |
| Please send me information about continuing education programs similar to this one. |
| |
| Privacy Statement: Information gathered will be used only for maintenance
of your credit certificate(s) with the Continuing Education Alliance
and will not be distributed to any third party. |
| |
|
|